{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:19:22Z","timestamp":1784809162230,"version":"3.55.0"},"reference-count":109,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cancer-associated fibroblasts (CAFs) are key components of the tumor microenvironment (TME) which promote drug resistance by remodeling the extracellular matrix, generating an immunosuppressive microenvironment, and activating metabolic signaling pathways. Nanomaterials provide an effective method for specifically targeting CAF-mediated drug resistance because of their unique targeted delivery capabilities, responsive release characteristics, and multifunctional integration. Here, we describe the mechanisms underlying the role of CAFs in drug resistance. The types of materials used and design principles are described, and examples of the application of nanomaterials for targeting CAFs are provided. Current challenges and future directions of nanomaterials targeting CAFs for reversing tumor drug resistance are also discussed to provide theoretical support for the development of effective nanotherapies aimed at reversing drug resistance in cancer.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1647988","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:35:30Z","timestamp":1763534130000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Advances in the study of reversing tumor drug resistance by targeting cancer-associated fibroblasts with nanomaterials"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaozhuo","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12032-025-02675-8","article-title":"Contribution of tumor microenvironment (TME) to tumor apoptosis, angiogenesis, metastasis, and drug resistance","volume":"42","author":"Xiao","year":"2025","journal-title":"Med Oncol (Northwood London England)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"102353","DOI":"10.1016\/j.tranon.2025.102353","article-title":"Immunomodulation on tumor immune microenvironment in acquired targeted therapy resistance and implication for immunotherapy resistance","volume":"54","author":"Chou","year":"2025","journal-title":"Trans Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S321416","article-title":"Nanoparticle-mediated targeted drug delivery to remodel tumor microenvironment for cancer therapy","volume":"16","author":"Tang","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12935-022-02599-7","article-title":"Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures","volume":"22","author":"Feng","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B5","doi-asserted-by":"publisher","first-page":"114895","DOI":"10.1016\/j.addr.2023.114895","article-title":"Stealth and pseudo-stealth nanocarriers","volume":"198","author":"Wen","year":"2023","journal-title":"Advanced Drug Delivery Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s44222-023-00138-1","article-title":"Controlling the biodistribution and clearance of nanomedicines","volume":"2","author":"Cabral","year":"2024","journal-title":"Nat Rev Bioeng"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.0c09029","article-title":"Chemo-physical strategies to advance the in vivo functionality of targeted nanomedicine: the next generation","volume":"143","author":"Li","year":"2021","journal-title":"J Am Chem Soc"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2009.11.017","article-title":"Origin and function of tumor stroma fibroblasts","volume":"21","author":"Xouri","year":"2010","journal-title":"Semin Cell Dev Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1038\/s41598-021-84058-3","article-title":"Adipose-derived mesenchymal stem cells differentiate into heterogeneous cancer-associated fibroblasts in a stroma-rich xenograft model","volume":"11","author":"Miyazaki","year":"2021","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.01.020","article-title":"Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth","volume":"19","author":"Quante","year":"2011","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/07357907.2019.1575969","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition in endometrial cancer cells by regulating pituitary tumor transforming gene","volume":"37","author":"Wang","year":"2019","journal-title":"Cancer Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.02.021","article-title":"Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth","volume":"153","author":"Cheng","year":"2013","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.10.023","article-title":"Tumor perivascular cell-derived extracellular vesicles promote angiogenesis via the Gas6\/Axl pathway","volume":"524","author":"Huang","year":"2022","journal-title":"Cancer Lett"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000320711","article-title":"Pancreatic cancer: the role of pancreatic stellate cells in tumor progression","volume":"10","author":"Dun\u00e9r","year":"2010","journal-title":"Pancreatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.canlet.2015.10.035","article-title":"Key role of pancreatic stellate cells in pancreatic cancer","volume":"381","author":"Pothula","year":"2016","journal-title":"Cancer Lett"},{"key":"B16","doi-asserted-by":"publisher","first-page":"112666","DOI":"10.1016\/j.intimp.2024.112666","article-title":"EBF1-COX4I2 signaling axis promotes a myofibroblast-like phenotype in cancer-associated fibroblasts (CAFs) and is associated with an immunosuppressive microenvironment","volume":"139","author":"Li","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1038\/s41598-021-83685-0","article-title":"Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer","volume":"11","author":"Mieulet","year":"2021","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010612","article-title":"Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6\/Jak\/Stat3 in PD-L1-high lung cancer","volume":"13","author":"Jeong","year":"2025","journal-title":"J Immunotherapy Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","article-title":"Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response","volume":"16","author":"Song","year":"2025","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.05.007","article-title":"Hungry for fat: Metabolic crosstalk with lipid-rich CAFs fuels pancreatic cancer","volume":"36","author":"Papavassiliou","year":"2024","journal-title":"Cell Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202937","article-title":"Tumor cell-intrinsic SETD2 deficiency reprograms neutrophils to foster immune escape in pancreatic tumorigenesis","volume":"10","author":"Niu","year":"2023","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2010.00157","article-title":"Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization","volume":"17","author":"Suzuki","year":"2011","journal-title":"Mol Med (Cambridge Mass)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biomaterials.2015.03.019","article-title":"Stiffening and unfolding of early deposited-fibronectin increase proangiogenic factor secretion by breast cancer-associated stromal cells","volume":"54","author":"Wang","year":"2015","journal-title":"Biomaterials"},{"key":"B24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12885-017-3953-6","article-title":"Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins","volume":"18","author":"Lovitt","year":"2018","journal-title":"BMC Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-3494","article-title":"Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment","volume":"74","author":"Yokoi","year":"2014","journal-title":"Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146987","article-title":"Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts","volume":"131","author":"Bhattacharjee","year":"2021","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1008902","article-title":"The role of tumor microenvironment reprogramming in primary liver cancer chemotherapy resistance","volume":"12","author":"Zhao","year":"2022","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ccell.2024.03.005","article-title":"Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer","volume":"42","author":"Niu","year":"2024","journal-title":"Cancer Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"113195","DOI":"10.1016\/j.yexcr.2022.113195","article-title":"TGF-\u03b21 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation","volume":"417","author":"Jena","year":"2022","journal-title":"Exp Cell Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgs196","article-title":"Hypoxia upregulates CD147 through a combined effect of HIF-1\u03b1 and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors","volume":"33","author":"Ke","year":"2012","journal-title":"Carcinogenesis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgx034","article-title":"Enhanced glycolysis, regulated by HIF-1\u03b1 via MCT-4, promotes inflammation in arsenite-induced carcinogenesis","volume":"38","author":"Luo","year":"2017","journal-title":"Carcinogenesis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.225","article-title":"Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death","volume":"8","author":"Cheteh","year":"2017","journal-title":"Cell Death Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03828-8","article-title":"Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy","volume":"147","author":"Zhao","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ctrv.2017.10.003","article-title":"Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer","volume":"61","author":"Wu","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000170","article-title":"Triple inhibition of EGFR, Met, and VEGF suppresses regrowth of HGF-triggered, erlotinib-resistant lung cancer harboring an EGFR mutation","volume":"9","author":"Nakade","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/cells13161334","article-title":"Cancer-associated-fibroblast-mediated paracrine and autocrine SDF-1\/CXCR4 signaling promotes stemness and aggressiveness of colorectal cancers","volume":"13","author":"Chen","year":"2024","journal-title":"Cells"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29864","article-title":"CXCL12\/CXCR4 activation by cancer-associated fibroblasts promotes integrin \u03b21 clustering and invasiveness in gastric cancer","volume":"138","author":"Izumi","year":"2016","journal-title":"Int J Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030469","article-title":"The CXCL12 crossroads in cancer stem cells and their niche","volume":"13","author":"L\u00f3pez-Gil","year":"2021","journal-title":"Cancers"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-15547","article-title":"Cancer stem cell markers in eyelid sebaceous gland carcinoma: high expression of ALDH1, CD133, and ABCG2 correlates with poor prognosis","volume":"56","author":"Kim","year":"2015","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"27878","DOI":"10.1038\/srep27878","article-title":"Aldh1 expression and activity increase during tumor evolution in sarcoma cancer stem cell populations","volume":"6","author":"Martinez-Cruzado","year":"2016","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-025-00896-7","article-title":"The FOXP1-ABCG2 axis promotes the proliferation of cancer stem cells and induces chemoresistance in pancreatic cancer","volume":"32","author":"Hong","year":"2025","journal-title":"Cancer Gene Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31030091","article-title":"Modeling 5-FU-induced chemotherapy selection of a drug-resistant cancer stem cell subpopulation","volume":"31","author":"Ramovi\u0107 Hamzagi\u0107","year":"2024","journal-title":"Curr Oncol (Toronto Ont)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6714","article-title":"Radioresistant breast cancer cells exhibit increased resistance to chemotherapy and enhanced invasive properties due to cancer stem cells","volume":"40","author":"Ko","year":"2018","journal-title":"Oncol Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12885-023-11011-0","article-title":"FAP, CD10, and GPR77-labeled CAFs cause neoadjuvant chemotherapy resistance by inducing EMT and CSC in gastric cancer","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.148960","article-title":"Resident stroma-secreted chemokine CCL2 governs myeloid-derived suppressor cells in the tumor microenvironment","volume":"7","author":"Oo","year":"2022","journal-title":"JCI Insight"},{"key":"B46","doi-asserted-by":"publisher","first-page":"8681","DOI":"10.1038\/s41598-025-92817-9","article-title":"Circulating IL6 is involved in the infiltration of M2 macrophages and CD8+\u2009T cells","volume":"15","author":"Huang","year":"2025","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.042671","article-title":"CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization","volume":"284","author":"Roca","year":"2009","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"Huang","year":"2022","journal-title":"Cancer Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1665","article-title":"Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells","volume":"9","author":"Young","year":"2008","journal-title":"Nat Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187314","article-title":"Philbrook P et\u00a0al: Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells","volume":"12","author":"Sethumadhavan","year":"2017","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-19-0347","article-title":"Epigenetic changes in fibroblasts drive cancer metabolism and differentiation","volume":"26","author":"Mishra","year":"2019","journal-title":"Endocrine-Related Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.230425","article-title":"YAP\/TAZ functions and their regulation at a glance","volume":"133","author":"Pocaterra","year":"2020","journal-title":"J Cell Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-022-01221-6","article-title":"Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.coph.2016.05.002","article-title":"YAP\/TAZ as therapeutic targets in cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/IJN.S500591","article-title":"Drug delivery system targeting cancer-associated fibroblast for improving immunotherapy","volume":"20","author":"Zhang","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1039\/D2CS00352J","article-title":"Bioactive inorganic nanomaterials for cancer theranostics","volume":"52","author":"Pei","year":"2023","journal-title":"Chem Soc Rev"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.1c23166","article-title":"Sequential delivery of quercetin and paclitaxel for the fibrotic tumor microenvironment remodeling and chemotherapy potentiation via a dual-targeting hybrid micelle-in-liposome system","volume":"14","author":"Duan","year":"2022","journal-title":"ACS Appl Materials Interfaces"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2018.2553","article-title":"Multifunctional bismuth ferrite nanoparticles as magnetic localized dose enhancement in radiotherapy and imaging","volume":"14","author":"Rajaee","year":"2018","journal-title":"J Biomed Nanotechnology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202007017","article-title":"FAP-targeted photodynamic therapy mediated by ferritin nanoparticles elicits an immune response against cancer cells and cancer associated fibroblasts","volume":"31","author":"Zhou","year":"2021","journal-title":"Advanced Funct Materials"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020328","article-title":"Selective targeting of cancer-associated fibroblasts by engineered H-ferritin nanocages loaded with navitoclax","volume":"10","author":"Sitia","year":"2021","journal-title":"Cells"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2015.10.001","article-title":"A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts","volume":"12","author":"Chen","year":"2016","journal-title":"Nanomedicine: Nanotechnology Biology Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3892\/or.2017.5601","article-title":"CRISPR\/Cas9-mediated genome engineering of CXCR4 decreases the Malignancy of hepatocellular carcinoma cells in vitro and in vivo","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/S1875-5364(18)30122-5","article-title":"The CXCL12 (SDF-1)\/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy","volume":"16","author":"Zhou","year":"2018","journal-title":"Chin J Natural Medicines"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2017.2404","article-title":"Complex of TNF-\u03b1 and modified fe(3)O(4) nanoparticles suppresses tumor growth by magnetic induction hyperthermia","volume":"32","author":"Teo","year":"2017","journal-title":"Cancer Biotherapy Radiopharmaceuticals"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S459400","article-title":"Fe(3)O(4) nanoparticles that modulate the polarisation of tumor-associated macrophages synergize with photothermal therapy and immunotherapy (PD-1\/PD-L1 inhibitors) to enhance anti-tumor therapy","volume":"19","author":"Sun","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"B68","doi-asserted-by":"publisher","first-page":"26","DOI":"10.7150\/ntno.38092","article-title":"FGF2 engineered SPIONs attenuate tumor stroma and potentiate the effect of chemotherapy in 3D heterospheroidal model of pancreatic tumor","volume":"4","author":"Mardhian","year":"2020","journal-title":"Nanotheranostics"},{"key":"B69","doi-asserted-by":"publisher","first-page":"118827","DOI":"10.1016\/j.carbpol.2021.118827","article-title":"pH-Sensitive nanoparticles based on amphiphilic imidazole\/cholesterol modified hydroxyethyl starch for tumor chemotherapy","volume":"277","author":"Xu","year":"2022","journal-title":"Carbohydr Polymers"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.3c00276","article-title":"Graphene Oxide Hosting a pH-Sensitive Prodrug: An In Silico Investigation of Graphene Oxide-Based Nanovehicle toward Cancer Therapy","volume":"6","author":"Zaboli","year":"2023","journal-title":"ACS Appl Bio Materials"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2019.01.026","article-title":"Enzyme-responsive multifunctional peptide coating of gold nanorods improves tumor targeting and photothermal therapy efficacy","volume":"86","author":"Wu","year":"2019","journal-title":"Acta Biomaterialia"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.8b00327","article-title":"Extracellular matrix component shelled nanoparticles as dual enzyme-responsive drug delivery vehicles for cancer therapy","volume":"4","author":"Zhou","year":"2018","journal-title":"ACS Biomaterials Sci Eng"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2017.2433","article-title":"Gelatin-encapsulated magnetic nanoparticles for pH, redox, and enzyme multiple stimuli-responsive drug delivery and magnetic resonance imaging","volume":"13","author":"Qi","year":"2017","journal-title":"J Biomed Nanotechnology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"112027","DOI":"10.1016\/j.msec.2021.112027","article-title":"Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy","volume":"123","author":"Vaghasiya","year":"2021","journal-title":"Materials Sci Eng C Materials Biol Appl"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.0c03022","article-title":"Mild acid-responsive \"Nanoenzyme capsule\" Remodeling of the tumor microenvironment to increase tumor penetration","volume":"12","author":"Yao","year":"2020","journal-title":"ACS Appl Materials Interfaces"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202400195","article-title":"Dual enzyme-encapsulated materials for biological cascade chemistry and synergistic tumor starvation","volume":"30","author":"Mishra","year":"2024","journal-title":"Chem (Weinheim an der Bergstrasse Germany)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3892\/mmr.2014.2452","article-title":"Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-\u03b2 signaling pathway","volume":"10","author":"Chen","year":"2014","journal-title":"Mol Med Rep"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14108","article-title":"Baicalein attenuates hypertrophic scar formation via inhibition of the transforming growth factor-\u03b2\/Smad2\/3 signalling pathway","volume":"174","author":"Zhang","year":"2016","journal-title":"Br J Dermatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029328","article-title":"Baicalin suppresses the migration and invasion of breast cancer cells via the TGF-\u03b2\/lncRNA-MALAT1\/miR-200c signaling pathway","volume":"101","author":"Li","year":"2022","journal-title":"Medicine"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2636","article-title":"CXCL12 (SDF1alpha)-CXCR4\/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies","volume":"17","author":"Duda","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.03.013","article-title":"CXCL12\/CXCR4 pathway orchestrates CSC-like properties by CAF recruited tumor associated macrophage in OSCC","volume":"378","author":"Li","year":"2019","journal-title":"Exp Cell Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.2174\/1381612821666150901103937","article-title":"Hollow inorganic nanoparticles as efficient carriers for siRNA delivery: A comprehensive review","volume":"21","author":"Varshosaz","year":"2015","journal-title":"Curr Pharm Design"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202305174","article-title":"Improved photodynamic therapy based on glutaminase blockage via tumor membrane coated CB-839\/IR-780 nanoparticles","volume":"20","author":"Li","year":"2024","journal-title":"Small (Weinheim an der Bergstrasse Germany)"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010950","article-title":"The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN","volume":"8","author":"Usart","year":"2024","journal-title":"Blood Adv"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/cphc.201900935","article-title":"Dual stimuli-responsive controlled release nanocarrier for multidrug resistance cancer therapy","volume":"20","author":"Jiao","year":"2019","journal-title":"Chemphyschem"},{"key":"B86","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1186\/s12951-024-02942-2","article-title":"Multifunctional nanoplatform with near-infrared triggered nitric-oxide release for enhanced tumor ferroptosis","volume":"22","author":"Wang","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202102269","article-title":"Activatable biomineralized nanoplatform remodels the intracellular environment of multidrug-resistant tumors for enhanced ferroptosis\/apoptosis therapy","volume":"17","author":"Wang","year":"2021","journal-title":"Small (Weinheim an der Bergstrasse Germany)"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.9b02118","article-title":"Theranostic nanoprobe mediated simultaneous monitoring and inhibition of P-glycoprotein potentiating multidrug-resistant cancer therapy","volume":"91","author":"Wei","year":"2019","journal-title":"Analytical Chem"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c22546","article-title":"Engineering dual-responsive nanoplatform achieves copper metabolism disruption and glutathione consumption to provoke cuproptosis\/ferroptosis\/apoptosis for cancer therapy","volume":"17","author":"Zhang","year":"2025","journal-title":"ACS Appl Materials Interfaces"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c02009","article-title":"Functional nucleic acids-engineered bio-barcode nanoplatforms for targeted synergistic therapy of multidrug-resistant cancer","volume":"17","author":"Zhi","year":"2023","journal-title":"ACS Nano"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006130","article-title":"Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6","volume":"11","author":"Lee","year":"2023","journal-title":"J Immunotherapy Cancer"},{"key":"B92","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41420-020-0272-5","article-title":"Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells","volume":"6","author":"Cheteh","year":"2020","journal-title":"Cell Death Discov"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.0c00163","article-title":"Tumor-targeting polycaprolactone nanoparticles with codelivery of paclitaxel and IR780 for combinational therapy of drug-resistant ovarian cancer","volume":"6","author":"Pan","year":"2020","journal-title":"ACS Biomaterials Sci Eng"},{"key":"B94","doi-asserted-by":"publisher","first-page":"114801","DOI":"10.1016\/j.ejmech.2022.114801","article-title":"Metal-organic frameworks (MOFs) as biomolecules drug delivery systems for anticancer purposes","volume":"244","author":"Coluccia","year":"2022","journal-title":"Eur J Medicinal Chem"},{"key":"B95","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.lfs.2018.03.044","article-title":"Nanoparticles designed to regulate tumor microenvironment for cancer therapy","volume":"201","author":"Li","year":"2018","journal-title":"Life Sci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-023-10572-3","article-title":"Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1-AXL signal relay in liver cancer cells","volume":"18","author":"Tanaka","year":"2024","journal-title":"Hepatol Int"},{"key":"B97","doi-asserted-by":"publisher","first-page":"125004","DOI":"10.1016\/j.ijpharm.2024.125004","article-title":"PD-L1 antibody conjugated dihydrotanshinone I-loaded polymeric nanoparticle for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death","volume":"667","author":"Wang","year":"2024","journal-title":"Int J Pharmaceutics"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-2864","article-title":"Anti-4-1BB\u00d7PDL1 bispecific antibody reinvigorates tumor-specific exhausted CD8+ T cells and enhances the efficacy of anti-PD1 blockade","volume":"30","author":"Jeon","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1021\/la304692h","article-title":"Smart photothermal-triggered bilayer phase transition in AuNPs-liposomes to release drug","volume":"29","author":"An","year":"2013","journal-title":"Langmuir: ACS J Surfaces Colloids"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2017.11.163","article-title":"NIR triggered liposome gold nanoparticles entrapping curcumin as in situ adjuvant for photothermal treatment of skin cancer","volume":"110","author":"Singh","year":"2018","journal-title":"Int J Biol Macromolecules"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/polym13071027","article-title":"Recent advancements in polymer\/liposome assembly for drug delivery: from surface modifications to hybrid vesicles","volume":"13","author":"De Leo","year":"2021","journal-title":"Polymers"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201603114","article-title":"Gd-hybridized plasmonic au-nanocomposites enhanced tumor-interior drug permeability in multimodal imaging-guided therapy","volume":"28","author":"Wang","year":"2016","journal-title":"Advanced Materials (Deerfield Beach Fla)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S113963","article-title":"IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy","volume":"12","author":"Fu","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.04.209","article-title":"Hybrid PEGylated chitosan\/PLGA nanoparticles designed as pH-responsive vehicles to promote intracellular drug delivery and cancer chemotherapy","volume":"210","author":"Huang","year":"2022","journal-title":"Int J Biol Macromolecules"},{"key":"B105","doi-asserted-by":"publisher","first-page":"105192","DOI":"10.1016\/j.tiv.2021.105192","article-title":"Multifunctional PLGA nanoparticles combining transferrin-targetability and pH-stimuli sensitivity enhanced doxorubicin intracellular delivery and in vitro antineoplastic activity in MDR tumor cells","volume":"75","author":"Scheeren","year":"2021","journal-title":"Toxicol Vitro"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1080\/1061186X.2024.2374034","article-title":"An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA\/MSN hybrid nanoparticles","volume":"32","author":"Tonbul","year":"2024","journal-title":"J Drug Targeting"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1039\/D1TB01092A","article-title":"Self-assembled Au(4)Cu(4)\/Au(25) NCs@liposome tumor nanotheranostics with PT\/fluorescence imaging-guided synergetic PTT\/PDT","volume":"9","author":"Liu","year":"2021","journal-title":"J Materials Chem B"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S219820","article-title":"Co-administration of iRGD enhances tumor-targeted delivery and anti-tumor effects of paclitaxel-loaded PLGA nanoparticles for colorectal cancer treatment","volume":"14","author":"Zhong","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01745.x","article-title":"Improved anti-tumor activity of stabilized anthracycline polymeric micelle formulation, NC-6300","volume":"102","author":"Harada","year":"2011","journal-title":"Cancer Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1647988\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:35:33Z","timestamp":1763534133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1647988\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":109,"alternative-id":["10.3389\/fimmu.2025.1647988"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1647988","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"article-number":"1647988"}}